Evidence map›Paper›PMID 33814457›Full record

ArticleJournal of neuromuscular diseases2021

Clinical Management of Duchenne Muscular Dystrophy in the Netherlands: Barriers to and Proposals for the Implementation of the International Clinical Practice Guidelines.

Lotte Heutinck, Maaike van Gameren, Jan J G M Verschuuren, Alexander C H Geurts, Merel Jansen, Imelda J M de Groot

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuromuscular diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
8.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Compliance to DMD Care Considerations in the Netherlands.Journal of neuromuscular diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Lotte HeutinckDonders Institute for Brain, Cognition, and Behaviour, Department of Rehabilitation, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
Maaike van GamerenDonders Institute for Brain, Cognition, and Behaviour, Department of Rehabilitation, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
Jan J G M VerschuurenDepartment of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Alexander C H GeurtsDonders Institute for Brain, Cognition, and Behaviour, Department of Rehabilitation, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
Merel JansenDe Hoogstraat, Utrecht, The Netherlands.
Imelda J M de GrootDonders Institute for Brain, Cognition, and Behaviour, Department of Rehabilitation, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
Radboud University Nijmegen · NLDe Hoogstraat Revalidatie · NLLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn order to successfully implement the international clinical care guidelines for Duchenne muscular dystrophy (DMD) in the Netherlands, it is essential to know what barriers are experienced by healthcare practitioners regarding guideline adherence and organization of care. In the Netherlands, academic medical centers provide follow up visits and work together with peripheral hospitals, rehabilitation centers, centers for home ventilation and primary care centers for treatment.

objectiveTo investigate perceived barriers to international clinical DMD guideline adherence and identify potential areas of improvement for implementation in the Dutch 'shared care' organization.

methodsSemi-structured in-depth interviews with healthcare practitioners of academic medical hospitals and questionnaires for healthcare practitioners of rehabilitation centers, based on the framework of Cabana.

resultsThe analyses identified 4 barriers for non-adherence to the DMD guideline: (i) lack of familiarity/awareness, (ii) lack of agreement with specific guideline, (iii) lack of outcome expectancy, (iv) external barriers.

conclusionsA heterogeneous set of barriers is present. Therefore, a multifaceted intervention strategy is proposed to overcome these barriers, including a clear division of roles, allowing for local (Dutch) adaptations per specialism by local consensus groups, and the facilitation of easy communication with experts/opinion leaders as well as between care professionals.

Indexed as

ConsensusFemaleGuideline AdherenceHealth PersonnelHumansMaleMuscular Dystrophy, DuchenneNetherlandsPractice Guidelines as TopicSurveys and Questionnairesclinical care guidelinesDuchenne muscular dystrophyguideline implementation

Identifiers

PMID33814457
PMCPMC8461703
OpenAlexW3144140082

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.